Vitrolife AB (VITR)

Stockholm
Currency in SEK
150.00
0.00(0.00%)
Real-time Data·
VITR Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
Earnings results expected in 6 days
Fair Value
Day's Range
149.60150.90
52 wk Range
134.40268.00
Key Statistics
Edit
Prev. Close
150
Open
150.9
Day's Range
149.6-150.9
52 wk Range
134.4-268
Volume
12.04K
Average Volume (3m)
171.43K
1-Year Change
-13.24%
Book Value / Share
96.92
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VITR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
222.50
Upside
+48.33%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Vitrolife AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Vitrolife AB Company Profile

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

Employees
1150
Market
Sweden

Vitrolife AB Earnings Call Summary for Q1/2025

  • Vitrolife's Q1 2025 EPS at 0.74 USD and revenue at 842M USD missed forecasts, leading to a 6.59% stock drop
  • Organic growth was 3%, excluding discontinued business; APAC region faced challenges impacting overall performance
  • Company maintains strong position in time-lapse technologies; gross margin improved from 57.1% to 57.4%
  • Focus on growth, innovation, and operational excellence; expects APAC recovery in latter half of 2025
  • Preparing for potential U.S. IVF reimbursement announcements; monitoring tariff impacts on supply chain
Last Updated: 2025-04-24, 05:38 a/m
Read Full Transcript

Compare VITR to Peers and Sector

Metrics to compare
VITR
Peers
Sector
Relationship
P/E Ratio
40.8x−13.9x−0.5x
PEG Ratio
0.36−0.310.00
Price/Book
1.5x8.0x2.6x
Price / LTM Sales
5.6x60.6x3.1x
Upside (Analyst Target)
56.7%18.8%45.7%
Fair Value Upside
Unlock4.0%5.7%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 222.50
(+48.33% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.68%
Dividend Yield
0.73%
Annualized payout
1.10
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.74 / 0.986
Revenue / Forecast
842.00M / 897.08M
EPS Revisions
Last 90 days

VITR Income Statement

People Also Watch

22.58
HTRO
-0.53%
61.9000
QTCOM
-1.04%
224.6
SKFb
-0.71%
296.20
BONEX
-1.00%
19.765
AMPF
-2.25%

FAQ

What Is the Vitrolife (VITR) Stock Price Today?

The Vitrolife stock price today is 150.00

What Stock Exchange Does Vitrolife Trade On?

Vitrolife is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Vitrolife?

The stock symbol for Vitrolife is "VITR."

Does Vitrolife Pay Dividends? What’s The Current Dividend Yield?

The Vitrolife dividend yield is 0.73%.

What Is the Vitrolife Market Cap?

As of today, Vitrolife market cap is 20.33B.

What Is Vitrolife's Earnings Per Share (TTM)?

The Vitrolife EPS (TTM) is 3.68.

When Is the Next Vitrolife Earnings Date?

Vitrolife will release its next earnings report on Jul 17, 2025.

From a Technical Analysis Perspective, Is VITR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Vitrolife Stock Split?

Vitrolife has split 1 times.

How Many Employees Does Vitrolife Have?

Vitrolife has 1150 employees.

What is the current trading status of Vitrolife (VITR)?

As of Jul 11, 2025, Vitrolife (VITR) is trading at a price of 150.00, with a previous close of 150.00. The stock has fluctuated within a day range of 149.60 to 150.90, while its 52-week range spans from 134.40 to 268.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.